Cargando…

New imaging technologies for robotic kidney cancer surgery

OBJECTIVE: Kidney cancers account for approximately 2% of all newly diagnosed cancer in 2020. Among the primary treatment options for kidney cancer, urologist may choose between radical or partial nephrectomy, or ablative therapies. Nowadays, robotic-assisted partial nephrectomy (RAPN) for the manag...

Descripción completa

Detalles Bibliográficos
Autores principales: Puliatti, Stefano, Eissa, Ahmed, Checcucci, Enrico, Piazza, Pietro, Amato, Marco, Ferretti, Stefania, Scarcella, Simone, Rivas, Juan Gomez, Taratkin, Mark, Marenco, Josè, Rivero, Ines Belenchon, Kowalewski, Karl-Friedrich, Cacciamani, Giovanni, El-Sherbiny, Ahmed, Zoeir, Ahmed, El-Bahnasy, Abdelhamid M., De Groote, Ruben, Mottrie, Alexandre, Micali, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Second Military Medical University 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399539/
https://www.ncbi.nlm.nih.gov/pubmed/36035346
http://dx.doi.org/10.1016/j.ajur.2022.03.008
_version_ 1784772545671593984
author Puliatti, Stefano
Eissa, Ahmed
Checcucci, Enrico
Piazza, Pietro
Amato, Marco
Ferretti, Stefania
Scarcella, Simone
Rivas, Juan Gomez
Taratkin, Mark
Marenco, Josè
Rivero, Ines Belenchon
Kowalewski, Karl-Friedrich
Cacciamani, Giovanni
El-Sherbiny, Ahmed
Zoeir, Ahmed
El-Bahnasy, Abdelhamid M.
De Groote, Ruben
Mottrie, Alexandre
Micali, Salvatore
author_facet Puliatti, Stefano
Eissa, Ahmed
Checcucci, Enrico
Piazza, Pietro
Amato, Marco
Ferretti, Stefania
Scarcella, Simone
Rivas, Juan Gomez
Taratkin, Mark
Marenco, Josè
Rivero, Ines Belenchon
Kowalewski, Karl-Friedrich
Cacciamani, Giovanni
El-Sherbiny, Ahmed
Zoeir, Ahmed
El-Bahnasy, Abdelhamid M.
De Groote, Ruben
Mottrie, Alexandre
Micali, Salvatore
author_sort Puliatti, Stefano
collection PubMed
description OBJECTIVE: Kidney cancers account for approximately 2% of all newly diagnosed cancer in 2020. Among the primary treatment options for kidney cancer, urologist may choose between radical or partial nephrectomy, or ablative therapies. Nowadays, robotic-assisted partial nephrectomy (RAPN) for the management of renal cancers has gained popularity, up to being considered the gold standard. However, RAPN is a challenging procedure with a steep learning curve. METHODS: In this narrative review, different imaging technologies used to guide and aid RAPN are discussed. RESULTS: Three-dimensional visualization technology has been extensively discussed in RAPN, showing its value in enhancing robotic-surgery training, patient counseling, surgical planning, and intraoperative guidance. Intraoperative imaging technologies such as intracorporeal ultrasound, near-infrared fluorescent imaging, and intraoperative pathological examination can also be used to improve the outcomes following RAPN. Finally, artificial intelligence may play a role in the field of RAPN soon. CONCLUSION: RAPN is a complex surgery; however, many imaging technologies may play an important role in facilitating it.
format Online
Article
Text
id pubmed-9399539
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Second Military Medical University
record_format MEDLINE/PubMed
spelling pubmed-93995392022-08-26 New imaging technologies for robotic kidney cancer surgery Puliatti, Stefano Eissa, Ahmed Checcucci, Enrico Piazza, Pietro Amato, Marco Ferretti, Stefania Scarcella, Simone Rivas, Juan Gomez Taratkin, Mark Marenco, Josè Rivero, Ines Belenchon Kowalewski, Karl-Friedrich Cacciamani, Giovanni El-Sherbiny, Ahmed Zoeir, Ahmed El-Bahnasy, Abdelhamid M. De Groote, Ruben Mottrie, Alexandre Micali, Salvatore Asian J Urol Review OBJECTIVE: Kidney cancers account for approximately 2% of all newly diagnosed cancer in 2020. Among the primary treatment options for kidney cancer, urologist may choose between radical or partial nephrectomy, or ablative therapies. Nowadays, robotic-assisted partial nephrectomy (RAPN) for the management of renal cancers has gained popularity, up to being considered the gold standard. However, RAPN is a challenging procedure with a steep learning curve. METHODS: In this narrative review, different imaging technologies used to guide and aid RAPN are discussed. RESULTS: Three-dimensional visualization technology has been extensively discussed in RAPN, showing its value in enhancing robotic-surgery training, patient counseling, surgical planning, and intraoperative guidance. Intraoperative imaging technologies such as intracorporeal ultrasound, near-infrared fluorescent imaging, and intraoperative pathological examination can also be used to improve the outcomes following RAPN. Finally, artificial intelligence may play a role in the field of RAPN soon. CONCLUSION: RAPN is a complex surgery; however, many imaging technologies may play an important role in facilitating it. Second Military Medical University 2022-07 2022-06-01 /pmc/articles/PMC9399539/ /pubmed/36035346 http://dx.doi.org/10.1016/j.ajur.2022.03.008 Text en © 2022 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Puliatti, Stefano
Eissa, Ahmed
Checcucci, Enrico
Piazza, Pietro
Amato, Marco
Ferretti, Stefania
Scarcella, Simone
Rivas, Juan Gomez
Taratkin, Mark
Marenco, Josè
Rivero, Ines Belenchon
Kowalewski, Karl-Friedrich
Cacciamani, Giovanni
El-Sherbiny, Ahmed
Zoeir, Ahmed
El-Bahnasy, Abdelhamid M.
De Groote, Ruben
Mottrie, Alexandre
Micali, Salvatore
New imaging technologies for robotic kidney cancer surgery
title New imaging technologies for robotic kidney cancer surgery
title_full New imaging technologies for robotic kidney cancer surgery
title_fullStr New imaging technologies for robotic kidney cancer surgery
title_full_unstemmed New imaging technologies for robotic kidney cancer surgery
title_short New imaging technologies for robotic kidney cancer surgery
title_sort new imaging technologies for robotic kidney cancer surgery
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399539/
https://www.ncbi.nlm.nih.gov/pubmed/36035346
http://dx.doi.org/10.1016/j.ajur.2022.03.008
work_keys_str_mv AT puliattistefano newimagingtechnologiesforrobotickidneycancersurgery
AT eissaahmed newimagingtechnologiesforrobotickidneycancersurgery
AT checcuccienrico newimagingtechnologiesforrobotickidneycancersurgery
AT piazzapietro newimagingtechnologiesforrobotickidneycancersurgery
AT amatomarco newimagingtechnologiesforrobotickidneycancersurgery
AT ferrettistefania newimagingtechnologiesforrobotickidneycancersurgery
AT scarcellasimone newimagingtechnologiesforrobotickidneycancersurgery
AT rivasjuangomez newimagingtechnologiesforrobotickidneycancersurgery
AT taratkinmark newimagingtechnologiesforrobotickidneycancersurgery
AT marencojose newimagingtechnologiesforrobotickidneycancersurgery
AT riveroinesbelenchon newimagingtechnologiesforrobotickidneycancersurgery
AT kowalewskikarlfriedrich newimagingtechnologiesforrobotickidneycancersurgery
AT cacciamanigiovanni newimagingtechnologiesforrobotickidneycancersurgery
AT elsherbinyahmed newimagingtechnologiesforrobotickidneycancersurgery
AT zoeirahmed newimagingtechnologiesforrobotickidneycancersurgery
AT elbahnasyabdelhamidm newimagingtechnologiesforrobotickidneycancersurgery
AT degrooteruben newimagingtechnologiesforrobotickidneycancersurgery
AT mottriealexandre newimagingtechnologiesforrobotickidneycancersurgery
AT micalisalvatore newimagingtechnologiesforrobotickidneycancersurgery